Jakob Pallesen

Jakob Pallesen is currently a Senior Associate at BioInnovation Institute, where Jakob anchors several Bio Studio projects aimed at spinning out new life science startups. Prior to this, Jakob worked as a Postdoctoral Researcher at AstraZeneca specializing in medicinal chemistry. Jakob also has experience as a Postdoctoral Researcher at the University of Copenhagen, focusing on development of Keap1-Nrf2 inhibitors for CNS diseases. Jakob holds a Master of Science in Pharmaceutical Sciences and a Bachelor of Science in Pharmacy from the University of Copenhagen.